Clinical trial
Phase III Study of AK160 in Patients With Dupuytren's Contracture
NCT01588353 is registered in ClinicalTrials.gov with Asahi Kasei Therapeutics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Study of AK160 in Patients With Dupuytren's Contracture
- Lead sponsor
- Asahi Kasei Therapeutics Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- January 31, 2014
- Enrollment
- 104 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
dupuytren's contracture